688131 皓元医药
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)4.9379.35016.25327.69325.435
总资产报酬率 ROA (%)3.0626.47411.78418.35617.340
投入资产回报率 ROIC (%)3.5277.55513.86322.77122.380

边际利润分析
销售毛利率 (%)48.33651.44454.11856.67457.180
营业利润率 (%)9.72314.47421.64123.41220.633
息税前利润/营业总收入 (%)11.06214.57722.26124.78720.757
净利润/营业总收入 (%)8.48514.10519.66220.22317.955

收益指标分析
经营活动净收益/利润总额(%)141.947107.449109.025113.942106.093
价值变动净收益/利润总额(%)-2.0128.085-0.0570.9780.759
营业外收支净额/利润总额(%)-0.7520.995-0.111-0.051-0.030

偿债能力分析
流动比率 (X)1.9332.2174.9442.1603.440
速动比率 (X)0.8491.1093.8491.3842.226
资产负债率 (%)39.87435.18322.98638.40126.314
带息债务/全部投入资本 (%)24.56915.3670.69518.8093.854
股东权益/带息债务 (%)276.001492.78912,717.344405.3432,380.148
股东权益/负债合计 (%)150.143183.280332.471160.412280.020
利息保障倍数 (X)7.835-342.76634.56917.871159.546

营运能力分析
应收账款周转天数 (天)81.86263.74341.66837.54240.120
存货周转天数 (天)401.480344.748235.069247.717276.630